Cases & Deals

Baxter International invests in Bugworks Research

Clients Baxter International Inc.

Jones Day represented Baxter International Inc. in connection with its purchase of Series Seed Preferred Stock in a private placement by Bugworks Research, Inc., a discovery company that aims to discover novel biopharmaceutical assets for the treatment of antibiotic resistant bacterial infections.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.